Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
1.3.1 Data collection
1.4 Forecast parameters
1.5 Covid-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Vitamin K industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Application trends
2.1.4 Route of administration trends
2.1.5 Distribution channel trends
2.1.6 Regional trends
Chapter 3 Vitamin K Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising number of coagulation disorders and chronic diseases globally
3.3.1.2 Lifestyle and dietary changes leading to deficiency of vitamin K in developing countries
3.3.1.3 Increasing awareness and demand of vitamin supplements
3.3.2 Industry pitfalls & challenges
3.3.2.1 Side effects associated with vitamin K dosage
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By application
3.4.3 By route of administration
3.4.4 By distribution channel
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company positioning matrix, 2022
4.4 Competitive analysis of major market players, 2022
4.5 Strategic outlook matrix, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Vitamin K Market, By Type
5.1 Key type trends
5.2 Vitamin K1
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Vitamin K2
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Vitamin K Market, By Application
6.1 Key application trends
6.2 Osteoporosis
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Vitamin K-dependent clotting factors deficiency (VKCFD)
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Prothrombin deficiency
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Vitamin K deficiency bleeding (VKDB)
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Dermal applications
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Other applications
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Vitamin K Market, By Route of Administration
7.1 Key route of administration trends
7.2 Oral
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.2 Pills
7.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.3 Powders
7.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.4 Liquids
7.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Parenteral
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Topical
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Vitamin K Market, By Distribution Channel
8.1 Key distribution channel trends
8.2 Offline
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.2.2 Hypermarkets/ Supermarkets
8.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.2.3 Specialty stores
8.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million
8.2.4 Pharmacy stores
8.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million
8.3 Online
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Vitamin K Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Switzerland
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Amphastar Pharmaceuticals, Inc.
10.2 BASF SE
10.3 Country Life, LLC (Kikkoman Corporation)
10.4 DSM
10.5 Kappa Bioscience
10.6 Livealth Biopharma Pvt. Ltd.
10.7 NattoPharma ASA
10.8 NOW Foods
10.9 Pfizer Inc.
10.10 Solgar Inc
